1-6 of 6
Jacob Rotmensch
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Abstract P5-16-11: Ipatasertib (ipat) in combination with palbociclib (palbo) and fulvestrant (fulv) in patients (pts) with hormone receptor-positive (HR+) HER2-negative advanced breast cancer (aBC)

Mafalda Oliveira, Aditya Bardia, Sung-Bae Kim, Naoki Niikura, Cristina Hernando, Gustavo Werutsky, Yoland Antill, Pedro Liedke, Catherine Oakman, Eriko Tokunaga, Seth Wander, Vanessa Krause, Toshinari Yamashita, Frauke Schimmoller, Jacob Rotmensch, Heidi Savage, Rucha Sane, Nicholas Turner
Journal: Cancer Research
Cancer Res (2022) 82 (4_Supplement): P5-16-11.
https://doi.org/10.1158/1538-7445.SABCS21-P5-16-11
Published: 15 February 2022
View articletitled, Abstract P5-16-11: Ipatasertib (ipat) in combination with palbociclib (palbo) and fulvestrant (fulv) in patients (pts) with hormone receptor-positive (HR+) HER2-negative advanced breast cancer (aBC)
Journal Articles

Abstract PD1-05: Atezolizumab in combination with trastuzumab emtansine or with trastuzumab and pertuzumab in patients with HER2-positive breast cancer and atezolizumab with doxorubicin and cyclophosphamide in HER2-negative breast cancer: Safety and biomarker outcomes from a multi-cohort Phase Ib study

Erika Paige Hamilton, Virginia Kaklamani, Carla Falkson, Gregory A Vidal, Patrick J Ward, Monika Patre, Stephen Y Chui, Jacob Rotmensch, Kushagra Gupta, Luciana Molinero, Yijin Li, Leisha A Emens
Journal: Cancer Research
Cancer Res (2020) 80 (4_Supplement): PD1-05.
https://doi.org/10.1158/1538-7445.SABCS19-PD1-05
Published: 15 February 2020
View articletitled, Abstract PD1-05: Atezolizumab in combination with trastuzumab emtansine or with trastuzumab and pertuzumab in patients with HER2-positive breast cancer and atezolizumab with doxorubicin and cyclophosphamide in HER2-negative breast cancer: Safety and biomarker outcomes from a multi-cohort Phase Ib study
Journal Articles

Abstract 4642: GRP78 in association with VEGFR-2 detects early stage ovarian cancer.

Doungkamol Alongkronrusmee, Pincas Bitterman, Jacques S. Abramowicz, Janice M. Bahr, Sanjib Basu, Salvatore Grasso, Sameer Sharma, Jacob Rotmensch, Animesh Barua
Journal: Cancer Research
Cancer Res (2013) 73 (8_Supplement): 4642.
https://doi.org/10.1158/1538-7445.AM2013-4642
Published: 15 April 2013
View articletitled, Abstract 4642: GRP78 in association with VEGFR-2 detects early stage ovarian cancer.
Journal Articles

Abstract 3471: Anti-NMP autoantibodies together with serum levels of death receptor 6 (DR6) detect ovarian tumors at early stage .

Animesh Barua, Jacques S. Abramowicz, Janice M. Bahr, Salvatore A. Grasso, Sameer Sharma, Sanjib Basu, Jacob Rotmensch, Pincas Bitterman
Journal: Cancer Research
Cancer Res (2013) 73 (8_Supplement): 3471.
https://doi.org/10.1158/1538-7445.AM2013-3471
Published: 15 April 2013
View articletitled, Abstract 3471: Anti-NMP autoantibodies together with serum levels of death receptor 6 (DR6) detect ovarian tumors at early stage .
Journal Articles

Abstract 1497: Aldehyde dehydrogenase 1A1 expression is altered in ovarian cancer and is not associated with stem cells

Krishna Penumatsa, Animesh Barua, Seby Edassery, Pincas Bitterman, Jacob Rotmensch, Judith Luborsky
Journal: Cancer Research
Cancer Res (2010) 70 (8_Supplement): 1497.
https://doi.org/10.1158/1538-7445.AM10-1497
Published: 15 April 2010
View articletitled, Abstract 1497: Aldehyde dehydrogenase 1A1 expression is altered in ovarian cancer and is not associated with stem cells
Journal Articles

X-Ray and cis-Diamminedichloroplatinum(II) Cross-Resistance in Human Tumor Cell Lines

Jeffrey L. Schwartz, Jacob Rotmensch, Michael A. Beckett, Deborah R. Jaffe, Margaret Toohill, Susan M. Giovanazzi, Jennifer McIntosh, Ralph R. Weichselbaum
Journal: Cancer Research
Cancer Res (1988) 48 (18): 5133–5135.
Published: 01 September 1988
View articletitled, X-Ray and cis-Diamminedichloroplatinum(II) Cross-Resistance in Human Tumor Cell Lines
Open the PDF for X-Ray and cis-Diamminedichloroplatinum(II) Cross-Resistance in Human Tumor Cell Lines in another window